It has been reported that HGF/c-Met signaling is important in EMT and metastasis and its downstream PI3k/Akt/mTOR signaling is one of the major pathways activated in cancer cells, including lung cancer cells [29, 30]. This evidence concerns the gene MET and lung carcinoma.